{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:00:31Z","timestamp":1793653231117,"version":"4.5.1"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s43032-026-02155-y","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:23:06Z","timestamp":1784744586000},"page":"1507-1528","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Miswired Ovarian Ecosystem: LIF\/JAK\/STAT3 Distortion in PCOS"],"prefix":"10.1007","volume":"33","author":[{"given":"Anisha","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6064-7576","authenticated-orcid":false,"given":"Ravi Kumar","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Bhatacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manodeep","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"2155_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14:270\u201384.","journal-title":"Nat Rev Endocrinol"},{"key":"2155_CR2","unstructured":"Shukla A, Rasquin LI, Anastasopoulou C. Polycystic Ovarian Syndrome. In: StatPearls Treasure Island, FL: StatPearls Publishing. 2025. https:\/\/www.ncbi.nlm.nih.gov\/sites\/books\/NBK459251\/ Accessed 15 Nov 2025."},{"key":"2155_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2023-000548","author":"J Dong","year":"2023","unstructured":"Dong J, Rees DA. Polycystic ovary syndrome: pathophysiology and therapeutic opportunities. BMJ Med. 2023. https:\/\/doi.org\/10.1136\/bmjmed-2023-000548.","journal-title":"BMJ Med"},{"key":"2155_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/13880209.2016.1258425","volume":"55","author":"RK Rajan","year":"2017","unstructured":"Rajan RK, M. SSK, Balaji B. Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism. Pharm Biol. 2017;55:242\u201351.","journal-title":"Pharm Biol"},{"key":"2155_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/gb-2004-5-12-253","volume":"5","author":"K Yamaoka","year":"2004","unstructured":"Yamaoka K, Saharinen P, Pesu M, et al. The Janus kinases (Jaks). Genome Biol. 2004;5:253.","journal-title":"Genome Biol"},{"key":"2155_CR6","doi-asserted-by":"publisher","first-page":"8680","DOI":"10.1073\/pnas.151180898","volume":"98","author":"J-G Cheng","year":"2001","unstructured":"Cheng J-G, Chen JR, Hernandez L, et al. Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation. Proc Natl Acad Sci USA. 2001;98:8680\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2155_CR7","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1071\/RD20098","volume":"32","author":"ER Frost","year":"2020","unstructured":"Frost ER, Ford EA, Peters AE, et al. Signal transducer and activator of transcription (STAT) 1 and STAT3 are expressed in the human ovary and have Janus kinase 1-independent functions in the COV434 human granulosa cell line. Reprod Fertil Dev. 2020;32:1027\u201339.","journal-title":"Reprod Fertil Dev"},{"key":"2155_CR8","doi-asserted-by":"publisher","DOI":"10.4161\/jkst.25155","volume":"2","author":"P Suman","year":"2013","unstructured":"Suman P, Malhotra SS, Gupta SK. LIF-STAT signaling and trophoblast biology. JAK-STAT. 2013;2:e25155.","journal-title":"JAK-STAT"},{"key":"2155_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0303-7207(01)00746-8","volume":"188","author":"EE Nilsson","year":"2002","unstructured":"Nilsson EE, Kezele P, Skinner MK. Leukemia inhibitory factor (LIF) promotes the primordial to primary follicle transition in rat ovaries. Mol Cell Endocrinol. 2002;188:65\u201373.","journal-title":"Mol Cell Endocrinol"},{"key":"2155_CR10","doi-asserted-by":"publisher","unstructured":"Pe\u00f1a S, Rubio M, Vargas C, et al. Participation of leukaemia inhibitory factor in follicular development and steroidogenesis in rat ovaries. J Endocrinol. 2023;258(1):e220255. https:\/\/doi.org\/10.1530\/JOE-22-0255.","DOI":"10.1530\/JOE-22-0255"},{"key":"2155_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1191759","author":"K Wang","year":"2023","unstructured":"Wang K, Li Y. Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome. Front Endocrinol. 2023. https:\/\/doi.org\/10.3389\/fendo.2023.1191759.","journal-title":"Front Endocrinol"},{"key":"2155_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2023.100265","volume":"78","author":"X Zhao","year":"2023","unstructured":"Zhao X, Xiong Y, Shen Y. Leptin plays a role in the multiplication of and inflammation in ovarian granulosa cells in polycystic ovary syndrome through the JAK1\/STAT3 pathway. Clinics (Sao Paulo). 2023;78:100265.","journal-title":"Clinics (Sao Paulo)"},{"key":"2155_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygcen.2022.114138","volume":"330","author":"H Wang","year":"2023","unstructured":"Wang H, Feng X, Wang T, et al. Role and mechanism of the p-JAK2\/p-STAT3 signaling pathway in follicular development in PCOS rats. Gen Comp Endocrinol. 2023;330:114138.","journal-title":"Gen Comp Endocrinol"},{"key":"2155_CR14","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1172\/JCI98785","volume":"129","author":"S Stivala","year":"2019","unstructured":"Stivala S, Codilupi T, Brkic S, et al. Targeting compensatory MEK\/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms. J Clin Invest. 2019;129:1596\u2013611.","journal-title":"J Clin Invest"},{"key":"2155_CR15","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3390\/ijerph19031336","volume":"19","author":"J Parker","year":"2022","unstructured":"Parker J, O\u2019Brien C, Hawrelak J, et al. Polycystic ovary syndrome: an evolutionary adaptation to lifestyle and the environment. Int J Environ Res Public Health. 2022;19:1336.","journal-title":"Int J Environ Res Public Health"},{"key":"2155_CR16","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3390\/biomedicines10061305","volume":"10","author":"G Scarf\u00f2","year":"2022","unstructured":"Scarf\u00f2 G, Daniele S, Fusi J, et al. Metabolic and molecular mechanisms of diet and physical exercise in the management of polycystic ovarian syndrome. Biomedicines. 2022;10:1305.","journal-title":"Biomedicines"},{"key":"2155_CR17","first-page":"533","volume":"24","author":"JM Sutherland","year":"2018","unstructured":"Sutherland JM, Frost ER, Ford EA, et al. Janus kinase JAK1 maintains the ovarian reserve of primordial follicles in the mouse ovary. Mol Hum Reprod. 2018;24:533\u201342.","journal-title":"Mol Hum Reprod"},{"key":"2155_CR18","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.peptides.2005.08.002","volume":"27","author":"L Debeljuk","year":"2006","unstructured":"Debeljuk L. Tachykinins and ovarian function in mammals. Peptides. 2006;27:736\u201342.","journal-title":"Peptides"},{"key":"2155_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.108375","volume":"301","author":"T Kawada","year":"2025","unstructured":"Kawada T, Aoyama M, Matsubara S, et al. Ovarian tachykinin signaling system induces the growth of secondary follicles during the gonadotropin-independent process. J Biol Chem. 2025;301:108375.","journal-title":"J Biol Chem"},{"key":"2155_CR20","volume-title":"StatPearls","author":"E Cox","year":"2025","unstructured":"Cox E, Takov V. Embryology, ovarian follicle development. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2025."},{"key":"2155_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/rmb2.12371","volume":"20","author":"M Orisaka","year":"2021","unstructured":"Orisaka M, Miyazaki Y, Shirafuji A, et al. The role of pituitary gonadotropins and intraovarian regulators in follicle development: a mini-review. Reprod Med Biol. 2021;20:169\u201375.","journal-title":"Reprod Med Biol"},{"key":"2155_CR22","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/genes2010280","volume":"2","author":"U Graf","year":"2011","unstructured":"Graf U, Casanova EA, Cinelli P. The role of the leukemia inhibitory factor (LIF) - pathway in derivation and maintenance of murine pluripotent stem cells. Genes (Basel). 2011;2:280\u201397.","journal-title":"Genes (Basel)"},{"key":"2155_CR23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.cytogfr.2015.07.001","volume":"26","author":"NA Nicola","year":"2015","unstructured":"Nicola NA, Babon JJ. Leukemia inhibitory factor (LIF). Cytokine Growth Factor Rev. 2015;26:533\u201344.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2155_CR24","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.ncrna.2024.05.003","volume":"9","author":"X Lin","year":"2024","unstructured":"Lin X, Nie X, Deng P, et al. Whispers of the polycystic ovary syndrome theater: directing role of long noncoding RNAs. Non-Coding RNA Res. 2024;9:1023\u201332.","journal-title":"Non-Coding RNA Res"},{"key":"2155_CR25","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v16.i7.108789","volume":"16","author":"N Rambaran","year":"2025","unstructured":"Rambaran N, Islam MS. Decoding androgen excess in polycystic ovary syndrome: roles of insulin resistance and other key intraovarian and systemic factors. World J Diabetes. 2025;16:108789.","journal-title":"World J Diabetes"},{"key":"2155_CR26","doi-asserted-by":"publisher","unstructured":"Wang K, Li Y, Chen Y. Androgen excess: a hallmark of polycystic ovary syndrome. Front Endocrinol. 2023;258(1):e220255. https:\/\/doi.org\/10.3389\/fendo.2023.1273542.","DOI":"10.3389\/fendo.2023.1273542"},{"key":"2155_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3390\/biomedicines13020289","volume":"13","author":"ANM Yusuf","year":"2025","unstructured":"Yusuf ANM, Amri MF, Ugusman A, et al. Dysregulation of leukaemia inhibitory factor (LIF) signalling pathway by supraphysiological dose of testosterone in female Sprague Dawley rats during development of endometrial receptivity. Biomedicines. 2025;13:289.","journal-title":"Biomedicines"},{"key":"2155_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021203","volume":"25","author":"S Matsuyama","year":"2024","unstructured":"Matsuyama S, Whiteside S, Li S-Y. Implantation and decidualization in PCOS: unraveling the complexities of pregnancy. Int J Mol Sci. 2024;25:1203.","journal-title":"Int J Mol Sci"},{"issue":"66","key":"2155_CR29","first-page":"1","volume":"91","author":"GX Rosario","year":"2014","unstructured":"Rosario GX, Hondo E, Jeong J-W, et al. The LIF-mediated molecular signature regulating murine embryo implantation1. Biol Reprod. 2014;91(66):1\u201318.","journal-title":"Biol Reprod"},{"key":"2155_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12958-021-00802-4","volume":"19","author":"X Bai","year":"2021","unstructured":"Bai X, Zheng L, Li D, et al. Research progress of endometrial receptivity in patients with polycystic ovary syndrome: a systematic review. Reprod Biol Endocrinol. 2021;19:122.","journal-title":"Reprod Biol Endocrinol"},{"key":"2155_CR31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12935-021-01899-8","volume":"21","author":"F Khodabakhsh","year":"2021","unstructured":"Khodabakhsh F, Merikhian P, Eisavand MR, et al. Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling. Cancer Cell Int. 2021;21:200.","journal-title":"Cancer Cell Int"},{"key":"2155_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-74295-7","volume":"14","author":"S-Y Wei","year":"2024","unstructured":"Wei S-Y, Zhang J-L, Guan H-Q, et al. High androgen level during controlled ovarian stimulation cycle impairs endometrial receptivity in PCOS patients. Sci Rep. 2024;14:23100.","journal-title":"Sci Rep"},{"key":"2155_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1400880","author":"X Wen","year":"2024","unstructured":"Wen X, Wang L, Lv S. Follicular development and endometrial receptivity of different androgen phenotypes in women with polycystic ovary syndrome. Front Endocrinol. 2024. https:\/\/doi.org\/10.3389\/fendo.2024.1400880.","journal-title":"Front Endocrinol"},{"key":"2155_CR34","doi-asserted-by":"publisher","unstructured":"Gao Q, Ma C, Meng S, et al. Exploration of molecular features of PCOS with different androgen levels and immune-related prognostic biomarkers associated with implantation failure. Front Endocrinol. 2022;13:946504. https:\/\/doi.org\/10.3389\/fendo.2022.946504.","DOI":"10.3389\/fendo.2022.946504"},{"key":"2155_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12967-023-04116-4","volume":"21","author":"S Shabbir","year":"2023","unstructured":"Shabbir S, Khurram E, Moorthi VS, et al. The interplay between androgens and the immune response in polycystic ovary syndrome. J Transl Med. 2023;21:259.","journal-title":"J Transl Med"},{"key":"2155_CR36","doi-asserted-by":"publisher","first-page":"7218","DOI":"10.12659\/MSM.916385","volume":"25","author":"Z Zhuang","year":"2019","unstructured":"Zhuang Z, Pan X, Zhao K, et al. The effect of interleukin-6 (IL-6), interleukin-11 (IL-11), signal transducer and activator of transcription 3 (STAT3), and AKT signaling on adipocyte proliferation in a rat model of polycystic ovary syndrome. Med Sci Monit. 2019;25:7218\u201327.","journal-title":"Med Sci Monit"},{"key":"2155_CR37","doi-asserted-by":"publisher","DOI":"10.4274\/jtgga.galenos.2024.2024-6-10","author":"SM Thomas","year":"2024","unstructured":"Thomas SM, Veerabathiran R, Thomas SM. Evaluating the impact of LHCGR gene polymorphism on polycystic ovary syndrome: a comprehensive meta-analysis and power assessment. J Turk Ger Gynecol Assoc. 2024. https:\/\/doi.org\/10.4274\/jtgga.galenos.2024.2024-6-10.","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"2155_CR38","doi-asserted-by":"publisher","unstructured":"Anujan P, Owens L, Patel N, et al. Luteinizing hormone receptor (LHR) signaling in granulosa lutein (GL) cells from women with polycystic ovary syndrome (PCOS): therapeutic potential of an allosteric inhibitor of LHR action. Endocrine Abstracts. 2025;109:OC3.4. https:\/\/doi.org\/10.1530\/endoabs.109.OC3.4.","DOI":"10.1530\/endoabs.109.OC3.4"},{"key":"2155_CR39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.rbmo.2016.03.003","volume":"32","author":"V Kanamarlapudi","year":"2016","unstructured":"Kanamarlapudi V, Gordon UD, Bernal AL. Luteinizing hormone\/chorionic gonadotrophin receptor overexpressed in granulosa cells from polycystic ovary syndrome ovaries is functionally active. Reprod Biomed Online. 2016;32:635\u201341.","journal-title":"Reprod Biomed Online"},{"key":"2155_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","volume":"7","author":"M Li","year":"2022","unstructured":"Li M, Chi X, Wang Y, et al. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022;7:216.","journal-title":"Signal Transduct Target Ther"},{"key":"2155_CR41","doi-asserted-by":"publisher","unstructured":"Zhang Q, Yang Z, Ou X, et al. The role of immunity in insulin resistance in patients with polycystic ovary syndrome. Front Endocrinol. 2025;15:1464561. https:\/\/doi.org\/10.3389\/fendo.2024.1464561.","DOI":"10.3389\/fendo.2024.1464561"},{"key":"2155_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1149239","author":"X Zhao","year":"2023","unstructured":"Zhao X, An X, Yang C, et al. The crucial role and mechanism of insulin resistance in metabolic disease. Front Endocrinol. 2023. https:\/\/doi.org\/10.3389\/fendo.2023.1149239.","journal-title":"Front Endocrinol"},{"key":"2155_CR43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12575-025-00296-z","volume":"27","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Chu M, Ye M, et al. SOCS3: an immunological biomarker offering potential therapeutic targets for malignant tumors. Biol Proced Online. 2025;27:36.","journal-title":"Biol Proced Online"},{"key":"2155_CR44","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20181380","volume":"39","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Lv L, Liu Q, et al. Total flavonoids extracted from Nervilia fordii function in polycystic ovary syndrome through IL-6 mediated JAK2\/STAT3 signaling pathway. Biosci Rep. 2019;39:BSR20181380.","journal-title":"Biosci Rep"},{"key":"2155_CR45","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7624932","author":"R Dadachanji","year":"2018","unstructured":"Dadachanji R, Shaikh N, Mukherjee S. Genetic variants associated with hyperandrogenemia in PCOS pathophysiology. Genet Res Int. 2018. https:\/\/doi.org\/10.1155\/2018\/7624932.","journal-title":"Genet Res Int"},{"key":"2155_CR46","doi-asserted-by":"publisher","first-page":"10272","DOI":"10.1038\/s41598-017-09880-0","volume":"7","author":"JJ Lim","year":"2017","unstructured":"Lim JJ, Lima PDA, Salehi R, et al. Regulation of androgen receptor signaling by ubiquitination during folliculogenesis and its possible dysregulation in polycystic ovarian syndrome. Sci Rep. 2017;7:10272.","journal-title":"Sci Rep"},{"key":"2155_CR47","doi-asserted-by":"publisher","unstructured":"Orisaka M, Mizutani T, Miyazaki Y, et al. Chronic low-grade inflammation and ovarian dysfunction in women with polycystic ovarian syndrome, endometriosis, and aging. Front Endocrinol. 2023;14:1324429. https:\/\/doi.org\/10.3389\/fendo.2023.1324429.","DOI":"10.3389\/fendo.2023.1324429"},{"key":"2155_CR48","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1080\/15592294.2020.1754674","volume":"15","author":"B Echibur\u00fa","year":"2020","unstructured":"Echibur\u00fa B, Milagro F, Crisosto N, et al. DNA methylation in promoter regions of genes involved in the reproductive and metabolic function of children born to women with PCOS. Epigenetics. 2020;15:1178\u201394.","journal-title":"Epigenetics"},{"key":"2155_CR49","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ncrna.2024.01.002","volume":"9","author":"R Heidarzadehpilehrood","year":"2024","unstructured":"Heidarzadehpilehrood R, Pirhoushiaran M. Biomarker potential of competing endogenous RNA networks in polycystic ovary syndrome (PCOS). Non-Coding RNA Res. 2024;9:624\u201340.","journal-title":"Non-Coding RNA Res"},{"key":"2155_CR50","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/cbf.3507","volume":"38","author":"L Li","year":"2020","unstructured":"Li L, Zhu J, Ye F, et al. Upregulation of the lncRNA SRLR in polycystic ovary syndrome regulates cell apoptosis and IL-6 expression. Cell Biochem Funct. 2020;38:880\u20135.","journal-title":"Cell Biochem Funct"},{"key":"2155_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/srep38134","volume":"6","author":"S-Y Li","year":"2016","unstructured":"Li S-Y, Song Z, Song M-J, et al. Impaired receptivity and decidualization in DHEA-induced PCOS mice. Sci Rep. 2016;6:38134.","journal-title":"Sci Rep"},{"key":"2155_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112031","volume":"142","author":"C-Z Pei","year":"2021","unstructured":"Pei C-Z, Jin L, Baek K-H. Pathogenetic analysis of polycystic ovary syndrome from the perspective of omics. Biomed Pharmacother. 2021;142:112031.","journal-title":"Biomed Pharmacother"},{"key":"2155_CR53","doi-asserted-by":"publisher","first-page":"27899","DOI":"10.18632\/oncotarget.8544","volume":"7","author":"J Xu","year":"2016","unstructured":"Xu J, Bao X, Peng Z, et al. Comprehensive analysis of genome-wide DNA methylation across human polycystic ovary syndrome ovary granulosa cell. Oncotarget. 2016;7:27899\u2013909.","journal-title":"Oncotarget"},{"key":"2155_CR54","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200632R","volume":"36","author":"X Yao","year":"2022","unstructured":"Yao X, El-Samahy MA, Li X, et al. LncRNA-412.25 activates the LIF\/STAT3 signaling pathway in ovarian granulosa cells of Hu sheep by sponging miR-346. FASEB J. 2022;36:e22467.","journal-title":"FASEB J"},{"key":"2155_CR55","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.3390\/ijms22083923","volume":"22","author":"SA Dabravolski","year":"2021","unstructured":"Dabravolski SA, Nikiforov NG, Eid AH, et al. Mitochondrial dysfunction and chronic inflammation in polycystic ovary syndrome. Int J Mol Sci. 2021;22:3923.","journal-title":"Int J Mol Sci"},{"key":"2155_CR56","doi-asserted-by":"publisher","first-page":"6594","DOI":"10.18632\/aging.204232","volume":"14","author":"R Gong","year":"2022","unstructured":"Gong R, Han R, Zhuang X, et al. MiR-375 mitigates retinal angiogenesis by depressing the JAK2\/STAT3 pathway. Aging (Albany NY). 2022;14:6594\u2013604.","journal-title":"Aging (Albany NY)"},{"key":"2155_CR57","doi-asserted-by":"publisher","first-page":"5959","DOI":"10.2147\/IJGM.S324126","volume":"14","author":"P Huang","year":"2021","unstructured":"Huang P, Du S, Lin Y, et al. Identification of three potential circRNA biomarkers of polycystic ovary syndrome by bioinformatics analysis and validation. Int J Gen Med. 2021;14:5959\u201368.","journal-title":"Int J Gen Med"},{"key":"2155_CR58","doi-asserted-by":"publisher","first-page":"785","DOI":"10.5114\/aoms.2019.89254","volume":"17","author":"L Li","year":"2019","unstructured":"Li L, Wei J, Hei J, et al. Long non-coding RNA H19 regulates proliferation of ovarian granulosa cells via STAT3 in polycystic ovarian syndrome. Arch Med Sci. 2019;17:785\u201391.","journal-title":"Arch Med Sci"},{"key":"2155_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112744","volume":"13","author":"M Papatsirou","year":"2021","unstructured":"Papatsirou M, Artemaki PI, Karousi P, et al. Circular RNAs: emerging regulators of the major signaling pathways involved in cancer progression. Cancers (Basel). 2021;13:2744.","journal-title":"Cancers (Basel)"},{"key":"2155_CR60","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.gendis.2021.10.009","volume":"9","author":"M Sajjadi-Dokht","year":"2022","unstructured":"Sajjadi-Dokht M, Merza Mohamad TA, Sulaiman Rahman H, et al. MicroRNAs and JAK\/STAT3 signaling: a new promising therapeutic axis in blood cancers. Genes Dis. 2022;9:849\u201367.","journal-title":"Genes Dis"},{"key":"2155_CR61","doi-asserted-by":"publisher","first-page":"16633","DOI":"10.18632\/oncotarget.15114","volume":"8","author":"R Wei","year":"2017","unstructured":"Wei R, Yang Q, Han B, et al. MicroRNA-375 inhibits colorectal cancer cells proliferation by downregulating JAK2\/STAT3 and MAP3K8\/ERK signaling pathways. Oncotarget. 2017;8:16633\u201341.","journal-title":"Oncotarget"},{"key":"2155_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11102909","volume":"11","author":"J Xiao","year":"2022","unstructured":"Xiao J, Joseph S, Xia M, et al. Circular RNAs acting as miRNAs\u2019 sponges and their roles in stem cells. J Clin Med. 2022;11:2909.","journal-title":"J Clin Med"},{"key":"2155_CR63","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/ncrna10050049","volume":"10","author":"H Yuan","year":"2024","unstructured":"Yuan H, Liao X, Hu D, et al. Back to the origin: mechanisms of circRNA-directed regulation of host genes in human disease. Non-Coding RNA. 2024;10:49.","journal-title":"Non-Coding RNA"},{"key":"2155_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.664843","volume":"9","author":"P Cao","year":"2021","unstructured":"Cao P, Yang W, Wang P, et al. Characterization of DNA methylation and screening of epigenetic markers in polycystic ovary syndrome. Front Cell Dev Biol. 2021;9:664843.","journal-title":"Front Cell Dev Biol"},{"key":"2155_CR65","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ajpath.2024.02.003","volume":"194","author":"P Cao","year":"2024","unstructured":"Cao P, Li H, Wang P, et al. DNA hypomethylation-mediated transcription dysregulation participates in pathogenesis of polycystic ovary syndrome. Am J Pathol. 2024;194:894\u2013911.","journal-title":"Am J Pathol"},{"key":"2155_CR66","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00404-025-08048-w","volume":"312","author":"Y Zhong","year":"2025","unstructured":"Zhong Y, Ding J, Xia F. DNA methylation and its impact on ovarian steroidogenesis in women with polycystic ovary syndrome: insights from human and animal models. Arch Gynecol Obstet. 2025;312:363\u201374.","journal-title":"Arch Gynecol Obstet"},{"key":"2155_CR67","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/GRF.0000000000000581","volume":"64","author":"JC Combs","year":"2021","unstructured":"Combs JC, Hill MJ, Decherney AH. Polycystic ovarian syndrome genetics and epigenetics. Clin Obstet Gynecol. 2021;64:20\u20135.","journal-title":"Clin Obstet Gynecol"},{"key":"2155_CR68","doi-asserted-by":"publisher","first-page":"20656","DOI":"10.18632\/oncotarget.9327","volume":"8","author":"S Li","year":"2017","unstructured":"Li S, Zhu D, Duan H, et al. Differential DNA methylation patterns of polycystic ovarian syndrome in whole blood of Chinese women. Oncotarget. 2017;8:20656\u201366.","journal-title":"Oncotarget"},{"key":"2155_CR69","doi-asserted-by":"publisher","first-page":"H776","DOI":"10.1152\/ajpheart.00570.2012","volume":"304","author":"K Dhar","year":"2013","unstructured":"Dhar K, Rakesh K, Pankajakshan D, et al. SOCS3 promotor hypermethylation and STAT3-NF-\u03baB interaction downregulate SOCS3 expression in human coronary artery smooth muscle cells. Am J Physiol Heart Circ Physiol. 2013;304:H776-785.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2155_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091829","volume":"9","author":"Y Feng","year":"2014","unstructured":"Feng Y, Wang Z, Bao Z, et al. SOCS3 promoter hypermethylation is a favorable prognosticator and a novel indicator for G-CIMP-positive GBM patients. PLoS ONE. 2014;9:e91829.","journal-title":"PLoS ONE"},{"key":"2155_CR71","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.2147\/JIR.S506050","volume":"18","author":"J-H Li","year":"2025","unstructured":"Li J-H, Tang Y, Wang J, et al. A clinical predictive model based on SOCS3 promoter methylation to predict the prognosis of acute-on-chronic hepatitis B liver failure. J Inflamm Res. 2025;18:3741\u201356.","journal-title":"J Inflamm Res"},{"key":"2155_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.620241","volume":"12","author":"Y Qin","year":"2021","unstructured":"Qin Y, Li T, Zhao H, et al. Integrated transcriptomic and epigenetic study of PCOS: impact of Map3k1 and Map1lc3a promoter methylation on autophagy. Front Genet. 2021;12:620241.","journal-title":"Front Genet"},{"key":"2155_CR73","doi-asserted-by":"publisher","first-page":"887","DOI":"10.5114\/aoms.2019.86060","volume":"15","author":"E Hosseini","year":"2019","unstructured":"Hosseini E, Shahhoseini M, Afsharian P, et al. Role of epigenetic modifications in the aberrant CYP19A1 gene expression in polycystic ovary syndrome. Arch Med Sci. 2019;15:887\u201395.","journal-title":"Arch Med Sci"},{"key":"2155_CR74","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3390\/biomedicines12030560","volume":"12","author":"CE L\u0151rincz","year":"2024","unstructured":"L\u0151rincz CE, B\u00f6rzsei D, Hoffmann A, et al. Mechanisms and target parameters in relation to polycystic ovary syndrome and physical exercise: focus on the master triad of hormonal changes, oxidative stress, and inflammation. Biomedicines. 2024;12:560.","journal-title":"Biomedicines"},{"key":"2155_CR75","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.7150\/thno.33444","volume":"9","author":"T Lu","year":"2019","unstructured":"Lu T, Bankhead A, Ljungman M, et al. Multi-omics profiling reveals key signaling pathways in ovarian cancer controlled by STAT3. Theranostics. 2019;9:5478\u201396.","journal-title":"Theranostics"},{"key":"2155_CR76","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1038\/s41598-024-81110-w","volume":"15","author":"X Zhu","year":"2025","unstructured":"Zhu X, Han Y, Feng Y, et al. Identification of molecular characteristics in polycystic ovary syndrome using single-cell and transcriptome analysis. Sci Rep. 2025;15:2970.","journal-title":"Sci Rep"},{"key":"2155_CR77","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s43587-024-00607-1","volume":"4","author":"M Wu","year":"2024","unstructured":"Wu M, Tang W, Chen Y, et al. Spatiotemporal transcriptomic changes of human ovarian aging and the regulatory role of FOXP1. Nat Aging. 2024;4:527\u201345.","journal-title":"Nat Aging"},{"key":"2155_CR78","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1210\/en.2017-00219","volume":"159","author":"M Wang","year":"2018","unstructured":"Wang M, Sun J, Xu B, et al. Functional characterization of microRNA-27a-3p expression in human polycystic ovary syndrome. Endocrinology. 2018;159:297\u2013309.","journal-title":"Endocrinology"},{"key":"2155_CR79","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1126\/science.1164551","volume":"323","author":"J Wegrzyn","year":"2009","unstructured":"Wegrzyn J, Potla R, Chwae Y-J, et al. Function of mitochondrial Stat3 in cellular respiration. Science. 2009;323:793\u20137.","journal-title":"Science"},{"key":"2155_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136439","volume":"26","author":"E Deer","year":"2025","unstructured":"Deer E, LaMarca B, Reckelhoff JF, et al. The role of mitochondrial dysfunction and oxidative stress in women\u2019s reproductive disorders: implications for polycystic ovary syndrome and preeclampsia. Int J Mol Sci. 2025;26:6439.","journal-title":"Int J Mol Sci"},{"key":"2155_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00121","author":"V Poli","year":"2015","unstructured":"Poli V, Camporeale A. STAT3-mediated metabolic reprograming in cellular transformation and implications for drug resistance. Front Oncol. 2015. https:\/\/doi.org\/10.3389\/fonc.2015.00121.","journal-title":"Front Oncol"},{"key":"2155_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1193749","author":"Y Gao","year":"2023","unstructured":"Gao Y, Zou Y, Wu G, et al. Oxidative stress and mitochondrial dysfunction of granulosa cells in polycystic ovarian syndrome. Front Med. 2023. https:\/\/doi.org\/10.3389\/fmed.2023.1193749.","journal-title":"Front Med"},{"key":"2155_CR83","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.neo.2021.10.003","volume":"23","author":"I To\u0161i\u0107","year":"2021","unstructured":"To\u0161i\u0107 I, Frank DA. STAT3 as a mediator of oncogenic cellular metabolism: pathogenic and therapeutic implications. Neoplasia. 2021;23:1167\u201378.","journal-title":"Neoplasia"},{"key":"2155_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.cophys.2023.100717","volume":"36","author":"AM Huffman","year":"2023","unstructured":"Huffman AM, Rezq S, Basnet J, et al. Biomarkers in polycystic ovary syndrome. Curr Opin Physiol. 2023;36:100717.","journal-title":"Curr Opin Physiol"},{"key":"2155_CR85","first-page":"7218","volume":"25","author":"Z Zhuang","year":"2019","unstructured":"Zhuang Z, Pan X, Zhao K, et al. The effect of interleukin-6 (IL-6), interleukin-11 (IL-11), signal transducer and activator of transcription 3 (STAT3), and AKT signaling on adipocyte proliferation in a rat model of polycystic ovary syndrome. Med Sci Monit Int Med J Exp Clin Res. 2019;25:7218\u201327.","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"2155_CR86","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1111\/jcmm.16205","volume":"25","author":"W Ye","year":"2021","unstructured":"Ye W, Xie T, Song Y, et al. The role of androgen and its related signals in PCOS. J Cell Mol Med. 2021;25:1825\u201337.","journal-title":"J Cell Mol Med"},{"key":"2155_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1140730","author":"C Di Giorgio","year":"2023","unstructured":"Di Giorgio C, Bellini R, Lupia A, et al. Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma. Front Oncol. 2023. https:\/\/doi.org\/10.3389\/fonc.2023.1140730.","journal-title":"Front Oncol"},{"key":"2155_CR88","doi-asserted-by":"publisher","first-page":"15388","DOI":"10.1038\/s41598-017-15342-4","volume":"7","author":"X Cheng","year":"2017","unstructured":"Cheng X, Peuckert C, W\u00f6lfl S. Essential role of mitochondrial Stat3 in p38MAPK mediated apoptosis under oxidative stress. Sci Rep. 2017;7:15388.","journal-title":"Sci Rep"},{"key":"2155_CR89","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s11684-017-0575-y","volume":"12","author":"Q Lai","year":"2018","unstructured":"Lai Q, Xiang W, Li Q, et al. Oxidative stress in granulosa cells contributes to poor oocyte quality and IVF-ET outcomes in women with polycystic ovary syndrome. Front Med. 2018;12:518\u201324.","journal-title":"Front Med"},{"key":"2155_CR90","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.cca.2022.04.234","volume":"531","author":"Y Luan","year":"2022","unstructured":"Luan Y, Zhang L, Peng Y, et al. Immune regulation in polycystic ovary syndrome. Clin Chim Acta. 2022;531:265\u201372.","journal-title":"Clin Chim Acta"},{"key":"2155_CR91","first-page":"313","volume":"21","author":"CJ Auernhammer","year":"2000","unstructured":"Auernhammer CJ, Melmed S. Leukemia-inhibitory factor\u2014neuroimmune modulator of endocrine function. Endocr Rev. 2000;21:313\u201345.","journal-title":"Endocr Rev"},{"key":"2155_CR92","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1071\/RD20098","volume":"32","author":"E Frost","year":"2020","unstructured":"Frost E, Ford E, Peters A, et al. STAT1 and STAT3 are expressed in the human ovary and have JAK1-independent functions in the COV434 human granulosa cell line. Reprod Fertil Dev. 2020;32:1027\u201339.","journal-title":"Reprod Fertil Dev"},{"key":"2155_CR93","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12958-022-00967-6","volume":"20","author":"G Guney","year":"2022","unstructured":"Guney G, Ta\u015fk\u0131n MI, Sener N, et al. The role of ERK-1 and ERK-2 gene polymorphisms in PCOS pathogenesis. Reprod Biol Endocrinol. 2022;20:95.","journal-title":"Reprod Biol Endocrinol"},{"key":"2155_CR94","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, et al. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther. 2021;6:402.","journal-title":"Signal Transduct Target Ther"},{"key":"2155_CR95","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/biolre\/iox106","volume":"97","author":"W-T Hung","year":"2017","unstructured":"Hung W-T, Navakanitworakul R, Khan T, et al. Stage-specific follicular extracellular vesicle uptake and regulation of bovine granulosa cell proliferation. Biol Reprod. 2017;97:644\u201355.","journal-title":"Biol Reprod"},{"key":"2155_CR96","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/s41388-018-0523-6","volume":"38","author":"K McLean","year":"2019","unstructured":"McLean K, Tan L, Bolland DE, et al. Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth. Oncogene. 2019;38:1576\u201384.","journal-title":"Oncogene"},{"key":"2155_CR97","doi-asserted-by":"publisher","first-page":"1191759","DOI":"10.3389\/fendo.2023.1191759","volume":"14","author":"K Wang","year":"2023","unstructured":"Wang K, Li Y. Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome. Front Endocrinol. 2023;14:1191759.","journal-title":"Front Endocrinol"},{"key":"2155_CR98","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41419-024-06594-w","volume":"15","author":"F Zhang","year":"2024","unstructured":"Zhang F, Yan Y, Cao X, et al. TGF-\u03b2-driven LIF expression influences neutrophil extracellular traps (NETs) and contributes to peritoneal metastasis in gastric cancer. Cell Death Dis. 2024;15:218.","journal-title":"Cell Death Dis"},{"key":"2155_CR99","first-page":"99","volume":"2","author":"N Xu","year":"2015","unstructured":"Xu N, Geller DH, Jones MR, et al. Comprehensive assessment of expression of insulin signaling pathway components in subcutaneous adipose tissue of women with and without polycystic ovary syndrome. J Clin Transl Endocrinol. 2015;2:99\u2013104.","journal-title":"J Clin Transl Endocrinol"},{"key":"2155_CR100","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022137","volume":"9","author":"K Luo","year":"2017","unstructured":"Luo K. Signaling cross talk between TGF-\u03b2\/Smad and other signaling pathways. Cold Spring Harb Perspect Biol. 2017;9:a022137.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2155_CR101","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/1933719113485294","volume":"21","author":"N Raja-Khan","year":"2014","unstructured":"Raja-Khan N, Urbanek M, Rodgers RJ, et al. The role of TGF-\u03b2 in polycystic ovary syndrome. Reprod Sci. 2014;21:20\u201331.","journal-title":"Reprod Sci"},{"key":"2155_CR102","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1074\/jbc.M116.773085","volume":"292","author":"L-Y Tang","year":"2017","unstructured":"Tang L-Y, Heller M, Meng Z, et al. Transforming growth factor-\u03b2 (TGF-\u03b2) directly activates the JAK1-STAT3 axis to induce hepatic fibrosis in coordination with the SMAD pathway. J Biol Chem. 2017;292:4302\u201312.","journal-title":"J Biol Chem"},{"key":"2155_CR103","doi-asserted-by":"publisher","first-page":"10824","DOI":"10.1038\/s41598-017-11252-7","volume":"7","author":"N Takahashi","year":"2017","unstructured":"Takahashi N, Harada M, Hirota Y, et al. Activation of endoplasmic reticulum stress in granulosa cells from patients with polycystic ovary syndrome contributes to ovarian fibrosis. Sci Rep. 2017;7:10824.","journal-title":"Sci Rep"},{"key":"2155_CR104","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/humrep\/deac049","volume":"37","author":"R Azumah","year":"2022","unstructured":"Azumah R, Liu M, Hummitzsch K, et al. Candidate genes for polycystic ovary syndrome are regulated by TGF\u03b2 in the bovine foetal ovary. Hum Reprod Oxf Engl. 2022;37:1244\u201354.","journal-title":"Hum Reprod Oxf Engl"},{"key":"2155_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.141455","volume":"306","author":"Y He","year":"2025","unstructured":"He Y, Gan M, Ma J, et al. TGF-\u03b2 signaling in the ovary: emerging roles in development and disease. Int J Biol Macromol. 2025;306:141455.","journal-title":"Int J Biol Macromol"},{"key":"2155_CR106","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1074\/jbc.M116.773085","volume":"292","author":"L-Y Tang","year":"2017","unstructured":"Tang L-Y, Heller M, Meng Z, et al. Transforming growth factor-\u03b2 (TGF-\u03b2) directly activates the JAK1-STAT3 axis to induce hepatic fibrosis in coordination with the SMAD pathway. J Biol Chem. 2017;292:4302\u201312.","journal-title":"J Biol Chem"},{"key":"2155_CR107","unstructured":"Guo Y, Sun Z, Liu Z, et al. The impact of TLR4 on insulin resistance and inflammatory factors in rats with polycystic ovary syndrome. Int J Clin Exp Med. 2018;11(11): 12239-12245."},{"key":"2155_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2021.101938","volume":"113","author":"D Nazarinia","year":"2021","unstructured":"Nazarinia D, Dolatshahi M, Faezi M, et al. TLR4 \/NF-\u0138B and JAK2\/STAT3 signaling pathways: cellular signaling pathways targeted by cell-conditioned medium therapy in protection against ischemic stroke. J Chem Neuroanat. 2021;113:101938.","journal-title":"J Chem Neuroanat"},{"key":"2155_CR109","doi-asserted-by":"crossref","unstructured":"Sun B, Pan Z, Kuang H, et al. TLR4\/NF-\u03baB signaling contributes to the inflammation in ovary and inguinal fats of polycystic ovary syndrome. 2022; 2022.07.14.500077.","DOI":"10.1101\/2022.07.14.500077"},{"key":"2155_CR110","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/201514","volume":"2014","author":"N Salleh","year":"2014","unstructured":"Salleh N, Giribabu N. Leukemia inhibitory factor: roles in embryo implantation and in nonhormonal contraception. Sci World J. 2014;2014:201514.","journal-title":"Sci World J"},{"key":"2155_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1110765","author":"Q Hu","year":"2023","unstructured":"Hu Q, Bian Q, Rong D, et al. JAK\/STAT pathway: extracellular signals, diseases, immunity, and therapeutic regimens. Front Bioeng Biotechnol. 2023. https:\/\/doi.org\/10.3389\/fbioe.2023.1110765.","journal-title":"Front Bioeng Biotechnol"},{"key":"2155_CR112","doi-asserted-by":"publisher","first-page":"7385160","DOI":"10.1155\/2021\/7385160","volume":"2021","author":"M Jiang","year":"2021","unstructured":"Jiang M, He J, Sun Y, et al. Leptin induced TLR4 expression via the JAK2-STAT3 pathway in obesity-related osteoarthritis. Oxid Med Cell Longev. 2021;2021:7385160.","journal-title":"Oxid Med Cell Longev"},{"key":"2155_CR113","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3892\/mmr.2021.12124","volume":"24","author":"DY Kang","year":"2021","unstructured":"Kang DY, Sp N, Jo ES, et al. Non-toxic sulfur inhibits LPS-induced inflammation by regulating TLR-4 and JAK2\/STAT3 through IL-6 signaling. Mol Med Rep. 2021;24:485.","journal-title":"Mol Med Rep"},{"key":"2155_CR114","doi-asserted-by":"publisher","first-page":"25726","DOI":"10.1038\/s41598-024-77265-1","volume":"14","author":"J-J Shin","year":"2024","unstructured":"Shin J-J, Suk K, Lee W-H. LncRNA BRE-AS1 regulates the JAK2\/STAT3-mediated inflammatory activation via the miR-30b-5p\/SOC3 axis in THP-1 cells. Sci Rep. 2024;14:25726.","journal-title":"Sci Rep"},{"key":"2155_CR115","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.cyto.2018.05.023","volume":"111","author":"MT Cantwell","year":"2018","unstructured":"Cantwell MT, Farrar JS, Lownik JC, et al. STAT3 suppresses Wnt\/\u03b2-catenin signaling during the induction phase of primary Myf5+ brown adipogenesis. Cytokine. 2018;111:434\u201344.","journal-title":"Cytokine"},{"key":"2155_CR116","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J, et al. Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7:3.","journal-title":"Signal Transduct Target Ther"},{"key":"2155_CR117","first-page":"269","volume":"129","author":"S Ye","year":"2016","unstructured":"Ye S, Zhang D, Cheng F, et al. Wnt\/\u03b2-catenin and LIF\u2013Stat3 signaling pathways converge on Sp5 to promote mouse embryonic stem cell self-renewal. J Cell Sci. 2016;129:269\u201376.","journal-title":"J Cell Sci"},{"key":"2155_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.943127","volume":"10","author":"G Risato","year":"2022","unstructured":"Risato G, Celeghin R, Bra\u00f1as Casas R, et al. Hyperactivation of Wnt\/\u03b2-catenin and Jak\/Stat3 pathways in human and zebrafish foetal growth restriction models: Implications for pharmacological rescue. Front Cell Dev Biol. 2022;10:943127.","journal-title":"Front Cell Dev Biol"},{"key":"2155_CR119","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jgyn.2015.08.013","volume":"46","author":"X-Q Wu","year":"2017","unstructured":"Wu X-Q, Wang Y-Q, Xu S-M, et al. The WNT\/\u03b2-catenin signaling pathway may be involved in granulosa cell apoptosis from patients with PCOS in North China. J Gynecol Obstet Hum Reprod. 2017;46:93\u20139.","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"2155_CR120","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12935-025-03946-0","volume":"25","author":"Y Feng","year":"2025","unstructured":"Feng Y, Gan X, Rong X, et al. The components and regulation of the Hippo pathway and its relationships with the progression and treatment of non-small cell lung cancer (NSCLC). Cancer Cell Int. 2025;25:309.","journal-title":"Cancer Cell Int"},{"key":"2155_CR121","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1172\/JCI88486","volume":"127","author":"W Kim","year":"2017","unstructured":"Kim W, Khan SK, Gvozdenovic-Jeremic J, et al. Hippo signaling interactions with Wnt\/\u03b2-catenin and notch signaling repress liver tumorigenesis. J Clin Invest. 2017;127:137\u201352.","journal-title":"J Clin Invest"},{"key":"2155_CR122","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.tcb.2018.03.001","volume":"28","author":"A Totaro","year":"2018","unstructured":"Totaro A, Castellan M, Di Biagio D, et al. Crosstalk between YAP\/TAZ and Notch signaling. Trends Cell Biol. 2018;28:560\u201373.","journal-title":"Trends Cell Biol"},{"key":"2155_CR123","doi-asserted-by":"publisher","first-page":"1623143","DOI":"10.3389\/fendo.2025.1623143","volume":"16","author":"J Wen","year":"2025","unstructured":"Wen J, Cheng G, Zhang Y, et al. Hippo signaling pathway in polycystic ovary syndrome. Front Endocrinol. 2025;16:1623143.","journal-title":"Front Endocrinol"},{"key":"2155_CR124","doi-asserted-by":"publisher","first-page":"19552","DOI":"10.1038\/s41598-023-46628-5","volume":"13","author":"J Ar\u00e9valo","year":"2023","unstructured":"Ar\u00e9valo J, Campoy I, Dur\u00e1n M, et al. STAT3 phosphorylation at serine 727 activates specific genetic programs and promotes clear cell renal cell carcinoma (ccRCC) aggressiveness. Sci Rep. 2023;13:19552.","journal-title":"Sci Rep"},{"key":"2155_CR125","doi-asserted-by":"publisher","DOI":"10.4161\/jkst.25686","volume":"2","author":"N Bausek","year":"2013","unstructured":"Bausek N. JAK-STAT signaling in stem cells and their niches in Drosophila. JAK-STAT. 2013;2:e25686.","journal-title":"JAK-STAT"},{"key":"2155_CR126","doi-asserted-by":"publisher","first-page":"1595362","DOI":"10.3389\/fcell.2025.1595362","volume":"13","author":"J Zhang","year":"2025","unstructured":"Zhang J, Wu H, Ren X, et al. Hippo\/YAP signaling\u2019s multifaceted crosstalk in cancer. Front Cell Dev Biol. 2025;13:1595362.","journal-title":"Front Cell Dev Biol"},{"key":"2155_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-75719-0","volume":"14","author":"S Dhar","year":"2024","unstructured":"Dhar S, Bhattacharjee P. Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment. Sci Rep. 2024;14:24468.","journal-title":"Sci Rep"},{"key":"2155_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1358755","author":"A Joshi","year":"2024","unstructured":"Joshi A. PCOS stratification for precision diagnostics and treatment. Front Cell Dev Biol. 2024. https:\/\/doi.org\/10.3389\/fcell.2024.1358755.","journal-title":"Front Cell Dev Biol"},{"key":"2155_CR129","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034514","volume":"102","author":"A Tiwari","year":"2023","unstructured":"Tiwari A, Modi SJ, Girme A, et al. Network pharmacology-based strategic prediction and target identification of apocarotenoids and carotenoids from standardized Kashmir saffron (Crocus sativus L.) extract against polycystic ovary syndrome. Medicine (Baltimore). 2023;102:e34514.","journal-title":"Medicine (Baltimore)"},{"key":"2155_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062665","volume":"26","author":"J Parker","year":"2025","unstructured":"Parker J, Hofstee P. Special issue \u2018new challenges and perspectives in polycystic ovary syndrome.\u2019 Int J Mol Sci. 2025;26:2665.","journal-title":"Int J Mol Sci"},{"key":"2155_CR131","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.1002\/ptr.70100","volume":"39","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Yang Z, Ou X, et al. Hesperidin inhibits oxidative stress and apoptosis of granulosa cells in polycystic ovarian syndrome through the JAK2\/STAT3 and PI3K\/AKT pathways. Phytother Res. 2025;39:5174\u201397.","journal-title":"Phytother Res"},{"key":"2155_CR132","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13048-020-00701-z","volume":"13","author":"Z Gao","year":"2020","unstructured":"Gao Z, Ma X, Liu J, et al. Troxerutin protects against DHT-induced polycystic ovary syndrome in rats. J Ovarian Res. 2020;13:106.","journal-title":"J Ovarian Res"},{"key":"2155_CR133","first-page":"8774","volume":"8","author":"G Bulut","year":"2015","unstructured":"Bulut G, Kurdoglu Z, D\u00f6nmez YB, et al. Effects of jnk inhibitor on inflammation and fibrosis in the ovary tissue of a rat model of polycystic ovary syndrome. Int J Clin Exp Pathol. 2015;8:8774\u201385.","journal-title":"Int J Clin Exp Pathol"},{"key":"2155_CR134","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.17305\/bb.2025.12676","volume":"25","author":"A\u00c7 G\u00fcndo\u011fdu","year":"2025","unstructured":"G\u00fcndo\u011fdu A\u00c7, Ar\u0131 NS, Ko\u00e7ak A, et al. Pirfenidone reduces ovarian fibrosis and improves PCOS in letrozole-induced rat model. Biomol Biomed. 2025;25:2558\u201369.","journal-title":"Biomol Biomed"},{"key":"2155_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1294406","author":"S Malik","year":"2024","unstructured":"Malik S, Saeed S, Saleem A, et al. Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs. Front Endocrinol. 2024. https:\/\/doi.org\/10.3389\/fendo.2023.1294406.","journal-title":"Front Endocrinol"},{"key":"2155_CR136","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12902-025-02035-7","volume":"25","author":"P Su","year":"2025","unstructured":"Su P, Xu Z, Pang L, et al. Effects of Genistein on polycystic ovary syndrome of rats: a systematic review and meta-analysis. BMC Endocr Disord. 2025;25:213.","journal-title":"BMC Endocr Disord"},{"key":"2155_CR137","doi-asserted-by":"publisher","DOI":"10.1515\/jbcpp-2019-0076","author":"OT Olaniyan","year":"2020","unstructured":"Olaniyan OT, Bamidele O, Adetunji CO, et al. Quercetin modulates granulosa cell mRNA androgen receptor gene expression in dehydroepiandrosterone-induced polycystic ovary in Wistar rats via metabolic and hormonal pathways. J Basic Clin Physiol Pharmacol. 2020. https:\/\/doi.org\/10.1515\/jbcpp-2019-0076.","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"2155_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2021.100161","volume":"2","author":"R Rani","year":"2022","unstructured":"Rani R, Hajam YA, Kumar R, et al. A landscape analysis of the potential role of polyphenols for the treatment of polycystic ovarian syndrome (PCOS). Phytomedicine Plus. 2022;2:100161.","journal-title":"Phytomedicine Plus"},{"key":"2155_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176119","volume":"960","author":"HS Anbar","year":"2023","unstructured":"Anbar HS, Vahora NY, Shah H, et al. Promising drug candidates for the treatment of polycystic ovary syndrome (PCOS) as alternatives to the classical medication metformin. Eur J Pharmacol. 2023;960:176119.","journal-title":"Eur J Pharmacol"},{"key":"2155_CR140","doi-asserted-by":"publisher","first-page":"337","DOI":"10.4155\/cli.14.133","volume":"5","author":"MA Ganie","year":"2015","unstructured":"Ganie MA, Chakraborty S, Rehman H. Treatment of polycystic ovary syndrome: recent trial results. Clin Investig. 2015;5:337\u201350.","journal-title":"Clin Investig"},{"key":"2155_CR141","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cct.2005.01.006","volume":"26","author":"ER Myers","year":"2005","unstructured":"Myers ER, Silva SG, Hafley G, et al. Estimating live birth rates after ovulation induction in polycystic ovary syndrome: sample size calculations for the pregnancy in polycystic ovary syndrome trial. Contemp Clin Trials. 2005;26:271\u201380.","journal-title":"Contemp Clin Trials"},{"key":"2155_CR142","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12958-024-01269-9","volume":"22","author":"M Zhao","year":"2024","unstructured":"Zhao M, Liao B, Yun C, et al. Liraglutide improves follicle development in polycystic ovary syndrome by inhibiting CXCL10 secretion. Reprod Biol Endocrinol. 2024;22:98.","journal-title":"Reprod Biol Endocrinol"},{"key":"2155_CR143","doi-asserted-by":"publisher","first-page":"932","DOI":"10.4239\/wjd.v12.i7.932","volume":"12","author":"J Marinkovic-Radosevic","year":"2021","unstructured":"Marinkovic-Radosevic J, Cigrovski Berkovic M, Kruezi E, et al. Exploring new treatment options for polycystic ovary syndrome: review of a novel antidiabetic agent SGLT2 inhibitor. World J Diabetes. 2021;12:932\u20138.","journal-title":"World J Diabetes"},{"key":"2155_CR144","unstructured":"Spencer-Jolliffe N. New medications for PCOS slowly edge toward development. Pharmaceutical Technology. 2023. https:\/\/www.pharmaceutical-technology.com\/features\/new-medications-for-pcos-slowly-edge-toward-development\/ Accessed 1 Dec 2025."},{"key":"2155_CR145","doi-asserted-by":"publisher","first-page":"1051111","DOI":"10.3389\/fendo.2022.1051111","volume":"13","author":"W Shen","year":"2022","unstructured":"Shen W, Qu Y, Jiang H, et al. Therapeutic effect and safety of curcumin in women with PCOS: a systematic review and meta-analysis. Front Endocrinol. 2022;13:1051111.","journal-title":"Front Endocrinol"},{"key":"2155_CR146","first-page":"195","volume":"40","author":"PM Spritzer","year":"2015","unstructured":"Spritzer PM, Motta AB, Sir-Petermann T, et al. Novel strategies in the management of polycystic ovary syndrome. Minerva Endocrinol. 2015;40:195\u2013212.","journal-title":"Minerva Endocrinol"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02155-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-026-02155-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02155-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T05:01:39Z","timestamp":1787202099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-026-02155-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":146,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2155"],"URL":"https:\/\/doi.org\/10.1007\/s43032-026-02155-y","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Tools such as Grammarly Premium and QuillBot Premium were used to enhance the readability and grammar of the manuscript.","order":1,"name":"Ethics","label":"Editing Declaration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}